Integrated epigenetic and transcriptomic analysis reveals low CD83 on B cells linked to refractory anti-PLA2R-associated membranous nephropathy
Background Anti-phospholipase A2 receptor (anti-PLA2R)-associated membranous nephropathy (MN) is a primary form of autoimmune glomerulonephritis causing nephrotic syndrome. MN can develop a refractory or relapsing clinical course, but biomarkers associated with poor prognosis remain poorly defined. Methods We performed single-nucleus RNA-sequencing (snRNA-seq) and ATAC-sequencing (snATAC-seq) of peripheral immune cells from five refractory/relapsing MN, six remission MN, twelve disease-control and seven healthy individuals (HCs), and GeoMx spatial transcriptomics of diagnostic kidney biopsies from eight refractory/relapsing MN, eight remission MN and eight HCs. Results B cells from refractory/relapsing MN showed significantly reduced CD83 expression. After re-clustering B cells according to CD83 expression, we found that the CD83-high B cells, characterized by upregulation of BACH2, FOXP1, and FOXO1 exhibited significantly lower CD83 expression in the refractory/relapsing MN. Regulatory T cells (Tregs) were also reduced in refractory/relapsing MN. Conversely, glomerular transcriptomes showed minimal differences between refractory/relapsing and remission MN. Conclusions Our findings suggest that CD83-high B cells and Tregs are potential biomarkers and therapeutic targets for refractory/relapsing MN.
Authors
- Christine Suh-Yun Joh (ORCID: https://orcid.org/0009-0005-6773-4265)
- Ji Hwan Moon (ORCID: https://orcid.org/0000-0002-0172-4428)
- Nicholas J. Steers
- Seung Seok Han (ORCID: https://orcid.org/0000-0003-0137-5261)
- Jang Hee Han (ORCID: https://orcid.org/0000-0003-4942-4632)
- Donggun Kim
- Kwon Wook Joo
- Chang Wook Jeong
- Jong-Il Kim
- Kookhwan Oh
- Yong Chul Kim
- Dong Ki Kim
- Hajeong Lee
- Minji Kang
- Seung Hee Yang
- Sehoon Park
- Seong Min Lee
- Hyun Je Kim
Institutions
- Seoul National University (KR)
- Columbia University Irving Medical Center (US)
- Samsung Medical Center (KR)
- Seoul National University Hospital (KR)
- Columbia University (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3389/fimmu.2026.1957278
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Seoul National University
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- Seoul National University Hospital
- Daewoong Pharmaceutical Company
- Ministry of Science and ICT, South Korea
- Korea National Institute of Health